Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27955603 | 0.84 | P2RX4 (0.44) | ALDH1A1KMT2AP2RX4KDM4EHSD17B10 | |
| SCHEMBL4886225 | 0.82 | TRPM8 (0.60) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| SCHEMBL2580705 | 0.80 | ALDH1A1 (0.60) | ALDH1A1KMT2AP2RX4KDM4EHSD17B10 | |
| SCHEMBL21350195 | 0.78 | ALDH1A1 (0.66) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| SCHEMBL19020352 | 0.78 | ALDH1A1 (0.66) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| SCHEMBL19020341 | 0.78 | ALDH1A1 (0.66) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| Methyl Benzoate SCHEMBL27918072 | 0.77 | TRPM8 (0.48) | ALDH1A1KMT2AP2RX4HPGDNPSR1 | |
| Hydrochloric Acid SCHEMBL18989476 | 0.77 | ALDH1A1 (0.65) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| SCHEMBL18980981 | 0.74 | ALDH1A1 (0.68) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 | |
| SCHEMBL18989618 | 0.74 | ALDH1A1 (0.55) | ALDH1A1KMT2AP2RX4KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120165559-A1 | Compounds Having a Physiological Effect | V. MANE FILS (FR) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165559-A1 | Compounds Having a Physiological Effect | NPPA, CYP11B2, SHBG | ALDH1A1 507/4885KMT2A 4572/4885P2RX4 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.